Cargando…

Future of Monoclonal Antibody Therapy in Parkinson’s Disease

Detalles Bibliográficos
Autores principales: Kharel, Sanjeev, Ojha, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259150/
https://www.ncbi.nlm.nih.gov/pubmed/37313331
http://dx.doi.org/10.1177/09727531221136349
_version_ 1785057607759691776
author Kharel, Sanjeev
Ojha, Rajeev
author_facet Kharel, Sanjeev
Ojha, Rajeev
author_sort Kharel, Sanjeev
collection PubMed
description
format Online
Article
Text
id pubmed-10259150
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-102591502023-06-13 Future of Monoclonal Antibody Therapy in Parkinson’s Disease Kharel, Sanjeev Ojha, Rajeev Ann Neurosci Commentary SAGE Publications 2022-11-17 2023-01 /pmc/articles/PMC10259150/ /pubmed/37313331 http://dx.doi.org/10.1177/09727531221136349 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Commentary
Kharel, Sanjeev
Ojha, Rajeev
Future of Monoclonal Antibody Therapy in Parkinson’s Disease
title Future of Monoclonal Antibody Therapy in Parkinson’s Disease
title_full Future of Monoclonal Antibody Therapy in Parkinson’s Disease
title_fullStr Future of Monoclonal Antibody Therapy in Parkinson’s Disease
title_full_unstemmed Future of Monoclonal Antibody Therapy in Parkinson’s Disease
title_short Future of Monoclonal Antibody Therapy in Parkinson’s Disease
title_sort future of monoclonal antibody therapy in parkinson’s disease
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259150/
https://www.ncbi.nlm.nih.gov/pubmed/37313331
http://dx.doi.org/10.1177/09727531221136349
work_keys_str_mv AT kharelsanjeev futureofmonoclonalantibodytherapyinparkinsonsdisease
AT ojharajeev futureofmonoclonalantibodytherapyinparkinsonsdisease